RECRUITING

Modulating Neurocognitive Processes of Learning to Trust and Distrust in Aging

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Much of human interaction is based on trust. Aging has been associated with deficits in trust-related decision making, likely further exacerbated in age-associated neurodegenerative disease (Alzheimer's disease/AD), possibly underlying the dramatically growing public health problem of elder fraud. Optimal trust-related decision making and avoiding exploitation require the ability to learn about the trustworthiness of social partners across multiple interactions, but the role that learning plays in determining age deficits in trust decisions is currently unknown. Aim: Probe the malleability of the underlying neurocircuitry of trust-learning deficits in aging. This study will utilize real-time fMRI neurofeedback to train older adults in brain activity up-regulation toward enhanced trust-related learning in aging and confirm critical mechanisms of experience-dependent social decisions in aging. Grant R01AG072658 Aim 3: Test the malleability of trust-learning neurocircuitry toward optimized trust-related decision making in aging.

Official Title

Characterizing and Modulating Neurocognitive Processes of Learning to Trust and Distrust in Aging II

Quick Facts

Study Start:2024-10-01
Study Completion:2027-03-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05457725

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 100 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Able to provide verbal and written informed consent
  2. * Fluent English speaker
  3. * At least 8th grade education
  4. * On stable medication regimen
  1. * Pregnancy
  2. * Magnetic resonance imaging contraindications (e.g., certain metallic objects in body, claustrophobia)
  3. * Current major depression defined as scores \>14 on the Beck Depression Inventory-II
  4. * Impaired scores on the Telephone Interview for Cognitive Status (TICS; cut-off of \>30)
  5. * Current use of medications with significant anticholinergic properties due to potential influence on memory ("memory enhancing"; e.g., Aricept or Namenda)
  6. * Current use of anticonvulsant, neuroleptic, sedatives, or other medications known to affect cognition
  7. * Uncorrected visual and hearing impairments
  8. * Neurologic conditions affecting the brain (e.g., severe stroke, epilepsy, traumatic brain injury with \>30-minute loss of consciousness)
  9. * Impaired scores on a cognitive screening measure, the Montreal Cognitive Assessment (MoCA); for older adults the cutoff will be age and education corrected
  10. * Unstable medical illness (e.g., metastatic cancer)
  11. * Significant cardiovascular conditions (e.g., major heart attack)
  12. * Will not exclude participants who are taking anti-depressant medications. Use of antidepressants (particularly SSRI's) and anxiolytic medications will be recorded and included in post-hoc analyses

Contacts and Locations

Study Contact

Dana Arnold, M.S.
CONTACT
401-617-6061
arnold.d@ufl.edu
Ryan Faulkner
CONTACT
727-771-5247
faulkerryan@ufl.edu

Principal Investigator

Natalie C. Ebner, PhD.
PRINCIPAL_INVESTIGATOR
University of Florida

Study Locations (Sites)

University of Florida
Gainesville, Florida, 32611
United States

Collaborators and Investigators

Sponsor: University of Florida

  • Natalie C. Ebner, PhD., PRINCIPAL_INVESTIGATOR, University of Florida

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-10-01
Study Completion Date2027-03-31

Study Record Updates

Study Start Date2024-10-01
Study Completion Date2027-03-31

Terms related to this study

Keywords Provided by Researchers

  • Decision Making
  • Trust
  • Learning
  • Socioemotional
  • Vulnerability to Exploitation

Additional Relevant MeSH Terms

  • Aging
  • Cognitive Change
  • Neurocognitive Disorders, Mild